Last reviewed · How we verify
NCT04243395: S55
Protein Source on Plasma Amino Acid Concentrations In Older Adults
NA trial testing Pork in Protein Deposition in 25 participants. Completed in 31 December 2021.
30 November 2021
Quick facts
| Lead sponsor | Purdue University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | diagnostic |
| Enrollment | 25 |
| Start date | 17 January 2020 |
| Primary completion | 30 November 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pork
- Egg
- Black beans
- Almonds
Conditions studied
- Protein Deposition — all drugs for Protein Deposition →
Sponsor
Purdue University
Who can join
Adults 55 to 75, any sex, with Protein Deposition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will determine the effect of the same ounce-equivalents of fresh pork versus nuts, beans, and eggs on postprandial plasma essential amino acid availability in older adults. Each participant will receive all four treatments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Consuming Ounce-Equivalent Portions of Animal- vs. Plant-Based Protein Foods, as Defined by the Dietary Guidelines for Americans on Essential Amino Acids Bioavailability in Young and Older Adults: Two Cross-Over Randomized Controlled Trials.
Connolly G, Hudson JL, Bergia RE, Davis EM, et al · · 2023 · cited 11× · PMID 37447197 · DOI 10.3390/nu15132870
Verify or expand the search:
- PubMed search for NCT04243395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pork
Trials testing the same drug.
- NCT03649568 — Protein Source on Plasma Amino Acid Concentrations · NA · completed
Other Purdue University trials
Trials by the same sponsor.
- NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
- NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
- NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04243395 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Purdue University
- Last refreshed: 28 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04243395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing